Toxicity Profiling and In Vivo Metabolism of Danshensu-Derived Novel Antihypertensive Candidate 221s (2,9).
Saved in:
| Title: | Toxicity Profiling and In Vivo Metabolism of Danshensu-Derived Novel Antihypertensive Candidate 221s (2,9). |
|---|---|
| Authors: | Chen Y; Xi'an Key Laboratory for Research and Development of Innovative Multi-Target Antihypertensive Drugs, Xi'an Innovative Antihypertensive Drugs International Science and Technology Cooperation Base, Xi'an Medical University, Xi'an 710021, China.; Institute of Drug Research, Xi'an Medical University, Xi'an 710021, China.; College of Pharmacy, Xi'an Medical University, Xi'an 710021, China., Yang K; Xi'an Key Laboratory for Research and Development of Innovative Multi-Target Antihypertensive Drugs, Xi'an Innovative Antihypertensive Drugs International Science and Technology Cooperation Base, Xi'an Medical University, Xi'an 710021, China.; Institute of Drug Research, Xi'an Medical University, Xi'an 710021, China.; College of Pharmacy, Xi'an Medical University, Xi'an 710021, China., Yu L; Xi'an Key Laboratory for Research and Development of Innovative Multi-Target Antihypertensive Drugs, Xi'an Innovative Antihypertensive Drugs International Science and Technology Cooperation Base, Xi'an Medical University, Xi'an 710021, China.; Institute of Drug Research, Xi'an Medical University, Xi'an 710021, China.; College of Pharmacy, Xi'an Medical University, Xi'an 710021, China., Wang R; Xi'an Key Laboratory for Research and Development of Innovative Multi-Target Antihypertensive Drugs, Xi'an Innovative Antihypertensive Drugs International Science and Technology Cooperation Base, Xi'an Medical University, Xi'an 710021, China.; Institute of Drug Research, Xi'an Medical University, Xi'an 710021, China.; College of Pharmacy, Xi'an Medical University, Xi'an 710021, China., Liu S; Xi'an Key Laboratory for Research and Development of Innovative Multi-Target Antihypertensive Drugs, Xi'an Innovative Antihypertensive Drugs International Science and Technology Cooperation Base, Xi'an Medical University, Xi'an 710021, China.; Institute of Drug Research, Xi'an Medical University, Xi'an 710021, China.; College of Pharmacy, Xi'an Medical University, Xi'an 710021, China., Qin B; Xi'an Key Laboratory for Research and Development of Innovative Multi-Target Antihypertensive Drugs, Xi'an Innovative Antihypertensive Drugs International Science and Technology Cooperation Base, Xi'an Medical University, Xi'an 710021, China.; Institute of Drug Research, Xi'an Medical University, Xi'an 710021, China.; College of Pharmacy, Xi'an Medical University, Xi'an 710021, China. |
| Source: | Toxins [Toxins (Basel)] 2025 Sep 01; Vol. 17 (9). Date of Electronic Publication: 2025 Sep 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651 (Electronic) Linking ISSN: 20726651 NLM ISO Abbreviation: Toxins (Basel) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6651 |
|---|---|
| DOI: | 10.3390/toxins17090436 |
